| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |